The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
Open accessAbstract
BACKGROUND: Active management of the third stage of labour reduces the risk of postpartum blood loss (postpartum haemorrhage (PPH)), and is defined as administration of a prophylactic uterotonic, early umbilical cord clamping and controlled cord traction to facilitate placental delivery. The choice of uterotonic varies across the globe and may have an impact on maternal outcomes. This is an update of a review first published in 2001 and last updated in 2013. OBJECTIVES: To determine the effectiveness of prophylactic oxytocin to prevent PPH and other adverse maternal outcomes in the third stage of labour. SEARCH METHODS: For this update, we searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (ICTRP) (6 March 2019) and reference lists of retrieved studies. SELECTION CRITERIA: Randomised, quasi- or cluster-randomised trials including women undergoing vaginal delivery who received prophylactic oxytocin during management of the third stage of labour. Primary outcomes were blood loss 500 mL or more after delivery, need for additional uterotonics, and maternal all-cause mortality. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion, extracted data, and assessed trial quality. Data were checked for accuracy. We assessed the quality of the evidence using the GRADE approach. MAIN RESULTS: This review includes 24 trials, with 23 trials involving 10,018 women contributing data. Due to many trials assessed at high risk of bias, evidence grade ranged from very low to moderate quality.Prophylactic oxytocin versus no uterotonics or placebo (nine trials)Prophylactic oxytocin compared with no uterotonics or placebo may reduce the risk of blood loss of 500 mL after delivery (average risk ratio (RR) 0.51, 95% confidence interval (C) 0.37 to 0.72; 4162 women; 6 studies; Tau² = 0.10, I² = 75%; low-quality evidence), and blood loss 1000 mL after delivery (RR 0.59, 95% CI 0.42 to 0.83; 4123 women; 5 studies; low-quality evidence). Prophylactic oxytocin probably reduces the need for additional uterotonics (average RR 0.54, 95% CI 0.36 to 0.80; 3135 women; 4 studies; Tau² = 0.07, I² = 44%; moderate-quality evidence). There may be no difference in the risk of needing a blood transfusion in women receiving oxytocin compared to no uterotonics or placebo (RR 0.88, 95% CI 0.44 to 1.78; 3081 women; 3 studies; low-quality evidence). Oxytocin may be associated with an increased risk of a third stage greater than 30 minutes (RR 2.55, 95% CI 0.88 to 7.44; 1947 women; 1 study; moderate-quality evidence), however the confidence interval is wide and includes 1.0, indicating that there may be little or no difference.Prophylactic oxytocin versus ergot alkaloids (15 trials)It is uncertain whether oxytocin reduces the likelihood of blood loss 500 mL (average RR 0.84, 95% CI 0.56 to 1.25; 3082 women; 10 studies; Tau² = 0.14, I² = 49%; very low-quality evidence) or the need for additional uterotonics compared to ergot alkaloids (average RR 0.89, 95% CI 0.43 to 1.81; 2178 women; 8 studies; Tau² = 0.76, I² = 79%; very low-quality evidence), because the quality of this evidence is very low. The quality of evidence was very low for blood loss of 1000 mL (RR 1.13, 95% CI 0.63 to 2.01; 1577 women; 3 studies; very low-quality evidence), and need for blood transfusion (average RR 1.37, 95% CI 0.34 to 5.51; 1578 women; 7 studies; Tau² = 1.34, I² = 45%; very low-quality evidence), making benefit of oxytocin over ergot alkaloids uncertain. Oxytocin probably increases the risk of a prolonged third stage greater than 30 minutes (RR 4.69, 95% CI 1.63 to 13.45; 450 women; 2 studies; moderate-quality evidence), although it is uncertain if this translates into increased risk of manual placental removal (average RR 1.10, 95% CI 0.39 to 3.10; 3127 women; 8 studies; Tau² = 1.07, I² = 76%; very low-quality evidence). Oxytocin may make little or no difference to risk of diastolic blood pressure > 100 mm Hg (average RR 0.28, 95% CI 0.04 to 2.05; 960 women; 3 studies; Tau² = 1.23, I² = 50%; low-quality evidence), and is probably associated with a lower risk of vomiting (RR 0.09, 95% CI 0.05 to 0.14; 1991 women; 7 studies; moderate-quality evidence), although the impact of oxytocin on headaches is uncertain (average RR 0.19, 95% CI 0.03 to 1.02; 1543 women; 5 studies; Tau² = 2.54, I² = 72%; very low-quality evidence).Prophylactic oxytocin-ergometrine versus ergot alkaloids (four trials)Oxytocin-ergometrine may slightly reduce the risk of blood loss greater than 500 mL after delivery compared to ergot alkaloids (RR 0.44, 95% CI 0.20 to 0.94; 1168 women; 3 studies; low-quality evidence), based on outcomes from quasi-randomised trials with a high risk of bias. There were no maternal deaths reported in either treatment group in the one trial that reported this outcome (RR not estimable; 1 trial, 807 women; moderate-quality evidence). Need for additional utero
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Active versus expectant management in the third stage of labour
Prendiville, W. J., Elbourne, D., & McDonald, S. J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000007 · Cited by 496
RetractedBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
Harbord, R. M., Egger, M., & Sterne, J. A. C. (2006) · Statistics in Medicine · doi:10.1002/sim.2380 · Cited by 2,267
Hogan, M. C., Foreman, K. J., Naghavi, M., Ahn, S. Y., Wang, M., Makela, S. M., Lopez, A. D., Lozano, R., & Murray, C. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60518-1 · Cited by 2,194
Effective Care in Pregnancy and Childbirth
Paintin, D. B. (1990) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb02464.x · Cited by 1,330
Lozano, R., Wang, H., Foreman, K. J., Rajaratnam, J. K., Naghavi, M., Marcus, J. R., Dwyer-Lindgren, L., Lofgren, K. T., Phillips, D., Atkinson, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61337-8 · Cited by 880
THE SEQUENCE OF AMINO ACIDS IN OXYTOCIN, WITH A PROPOSAL FOR THE STRUCTURE OF OXYTOCIN
du Vigneaud, V., Ressler, C., & Trippett, S. (1953) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49238-1 · Cited by 600
Global burden of maternal death and disability
AbouZahr, C. (2003) · British Medical Bulletin · doi:10.1093/bmb/ldg015 · Cited by 567
Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-1993
Stationery Office (1996) · HMSO eBooks · Cited by 477
Active versus expectant management for women in the third stage of labour
Begley, C. M., Gyte, G. M., Devane, D., McGuire, W., & Weeks, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007412.pub4 · Cited by 446
Effective care in pregnancy and childbirth
MacVicar, J. (1990) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(90)90113-f · Cited by 335
Visually estimated and calculated blood loss in vaginal and cesarean delivery
Stafford, I., Dildy, G. A., Clark, S. L., & Belfort, M. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.04.049 · Cited by 334
Tranexamic acid for preventing postpartum haemorrhage
Novikova, N., Hofmeyr, G. J., & Cluver, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007872.pub3 · Cited by 330
The Bristol third stage trial: active versus physiological management of third stage of labour.
Prendiville, W. J., Harding, J. E., Elbourne, D. R., & Stirrat, G. M. (1988) · BMJ · doi:10.1136/bmj.297.6659.1295 · Cited by 306
Prostaglandins for preventing postpartum haemorrhage
Tunçalp, Ö., Hofmeyr, G. J., & Gülmezoglu, A. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000494.pub4 · Cited by 296
Estimating Blood Loss: Can Teaching Significantly Improve Visual Estimation?
Dildy, G. A., Paine, A. R., George, N. C., & Velasco, C. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000137873.07820.34 · Cited by 245
Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery
Wetta, L. A., Szychowski, J. M., Seals, S., Mancuso, M. S., Biggio, J. R., & Tita, A. T. N. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.03.011 · Cited by 239
Prophylactic oxytocin for the third stage of labour
Cotter, A. M., Ness, A., & Tolosa, J. E. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001808 · Cited by 230
Self-citationProphylactic ergometrine-oxytocin versus oxytocin for the third stage of labour
McDonald, S. J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000201.pub2 · Cited by 201
PRENDIVILLE, W., ELBOURNE, D., & CHALMERS, I. (1988) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1988.tb06475.x · Cited by 201
Al Kadri, H. M. F., Al Anazi, B. K., & Tamim, H. M. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1522-1 · Cited by 199
The Accuracy of Blood Loss Estimation After Simulated Vaginal Delivery
Toledo, P., McCarthy, R. J., Hewlett, B. J., Fitzgerald, P. C., & Wong, C. A. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000286233.48111.d8 · Cited by 175
Active versus expectant management for women in the third stage of labour
Begley, C. M., Gyte, G. M., Devane, D., McGuire, W., & Weeks, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007412.pub3 · Cited by 171
Postpartum haemorrhage—a continuing problem
Gilbert, L. A., PORTER, W., & BROWN, V. A. (1987) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1987.tb02255.x · Cited by 166
Carbetocin for preventing postpartum haemorrhage
Su, L., Chong, Y. S., & Samuel, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005457.pub4 · Cited by 165
Routine oxytocin in the third stage of labour: a placebo controlled randomised trial
Nordström, L., Fogelstam, K., Fridman, G., Larsson, A., & Rydhstroem, H. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb12020.x · Cited by 164
de Groot, A. N. J. A., van Dongen, P. W. J., Vree, T. B., Hekster, Y. A., & van Roosmalen, J. (1998) · Drugs · doi:10.2165/00003495-199856040-00002 · Cited by 157
Blood loss during and immediately after delivery.
Newton, M. J., Mosey, L. M., Ge, E., Wb, G., & Ct, H. (1961) · PubMed · Cited by 127
BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health (1978) · Archives of Disease in Childhood · doi:10.1136/adc.53.6.524-b · Cited by 127
Prophylactic use of ergot alkaloids in the third stage of labour
Liabsuetrakul, T., Choobun, T., Peeyananjarassri, K., & Islam, Q. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005456.pub2 · Cited by 124
Khan, G. Q., John, I. S., Wani, S., Doherty, T., & Sibai, B. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70266-7 · Cited by 110
Boucher, M., Nimrod, C. A., Tawagi, G., Meeker, T. A., White, R. E. R., & Varin, J. (2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30659-4 · Cited by 99
Timing of prophylactic uterotonics for the third stage of labour after vaginal birth
Soltani, H., Hutchon, D. J. R., & Poulose, T. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006173.pub2 · Cited by 93
Umbilical vein injection for management of retained placenta
Kumar, N., Jahanfar, S., Haas, D. M., & Weeks, A. D. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001337.pub3 · Cited by 78
POESCHMANN, R. P., Doesburg, W. H., & Eskes, T. K. A. B. (1991) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1991.tb10364.x · Cited by 76
Postpartum haemorrhage: its contribution to maternal mortality
Kwast, B. E. (1991) · Midwifery · doi:10.1016/s0266-6138(05)80229-3 · Cited by 73
Beischer, N. A., & Mackay, E. V. (1978) · Cited by 73
A placebo‐controlled trial of oral ergometrine to reduce postpartum hemorrhage
de Groot, A. N. J. A., van Roosmalen, J., van Dongen, P. W. J., & Borm, G. F. (1996) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349609033355 · Cited by 69
Concomitant and repeated happenings of complications of the third stage of labour
Hall, M. H., Halliwell, R., & Carr‐Hill, R. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01456.x · Cited by 67
Plasma oxytocin during third stage of labour: comparison of natural and active management.
Thornton, S., Davison, J. M., & Baylis, P. H. (1988) · BMJ · doi:10.1136/bmj.297.6642.167 · Cited by 50
Stanton, C. K., Newton, S., Mullany, L. C., Cofie, P., Agyemang, C. T., Adiibokah, E., Amenga‐Etego, S., Darcy, N., Khan, S., Armbruster, D., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001524 · Cited by 50
Prophylactic syntometrine versus oxytocin for delivery of the placenta
McDonald, S., Prendiville, W. J., & Elbourne, D. R. (1996) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000201 · Cited by 48
Umbilical vein injection for management of retained placenta
Carroli, G., & Bergel, E. F. (2001) · doi:10.1002/14651858.cd001337 · Cited by 48
Comparative clinical evaluation of postpartum oxytocics
Friedman, E. A. (1957) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(57)90274-0 · Cited by 40
Oxytocic Drugs in Fourth Stage of Labor
Howard, W. F., McFadden, P. R., & Keettel, W. C. (1964) · JAMA · doi:10.1001/jama.1964.03070060021004 · Cited by 24
Umbilical vein injection for the routine management of third stage of labour
Mori, R., Nardin, J. M., Yamamoto, N., Carroli, G., & Weeks, A. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006176.pub2 · Cited by 23
BLOOD PRESSURE CHANGES WHEN UTERINE STIMULANTS ARE USED AFTER NORMAL DELIVERY
Hacker, N. F., & Biggs, J. S. G. (1979) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1979.tb10825.x · Cited by 17
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes
McDonald, S. J., Middleton, P., Dowswell, T., & Morris, P. S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004074.pub3 · Cited by 890
Rabe, H., Gyte, G. M., Díaz-Rossello, J. L., & Duley, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003248.pub4 · Cited by 677
Active versus expectant management for women in the third stage of labour
Begley, C. M., Gyte, G. M., Devane, D., McGuire, W., & Weeks, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007412.pub4 · Cited by 446
Treatment for primary postpartum haemorrhage
Mousa, H. A., Blum, J., Abou El Senoun, G., Shakur, H., & Alfirevic, Z. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003249.pub3 · Cited by 389
Metadata
- Authors
- Westhoff, G., Cotter, A. M., & Tolosa, J. E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-10-30
- Volume
- 4
- Issue
- 10
- Pages
- CD001808-CD001808
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2101258788
- Cited by
- 289
- References
- 49
- FWCI
- 24.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.